Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure

Glycoconjugate Journal

Volumn 24, Issue 9, 2007, Pages 565-571

  Hu, Rui ^a,b   Li, Gang ^a,b   Kamijo, Yuji ^c   Aoyama, Toshifumi ^a   Nakajima, Takero ^a   Inoue, Teruo ^d   Node, Koichi ^d   Kannagi, Reiji ^e   Kyogashima, Mamoru ^e   Hara, Atsushi ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SAGA UNIVERSITY   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cardiovascular disease; End stage renal failure; Hemodialysis; Serum sulfatides

Indexed keywords

BIOLOGICAL MARKER; SULFATIDE; SULFOGALACTOSYLSPHINGOSINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEMODIALYSIS; HIGH RISK POPULATION; HIGH THROUGHPUT SCREENING; HUMAN; INCIDENCE; KIDNEY FAILURE; LIPID BLOOD LEVEL; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MASS SPECTROMETRY; MIDDLE AGED; RENAL DIALYSIS; SULFOGLYCOSPHINGOLIPIDS;

EID: 35648955147     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-007-9053-0     Document Type: Article

References (28)

1. Ishizuka, I.: Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 36, 245-319 (1997)
2. Hara, A., Taketomi, T.: Occurrence of sulfatides as a major glycosphingolipid in WHHL rabbit serum lipoproteins. J. Biochem. (Tokyo) 102, 83-92 (1987)
3. Hara, A., Taketomi, T.: Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit. J. Biochem. (Tokyo) 109, 904-908 (1991)
4. Zhu, X.H., Hara, A., Taketomi, T.: The existence of galactosylceramide I3-sulfatides in serums of various mammals and its anticoagulant activity. J. Biochem. (Tokyo) 110, 241-245 (1991)
5. Hara, A., Kutsukake, Y., Uemura, K., Taketomi, T.: Anticoagulant activity of sulfatides and its anti-thrombotic effect in rabbit. J. Biochem. (Tokyo) 113, 781-785 (1993)
6. Hara, A., Uemura, K., Taketomi, T.: Sulfatides prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen. Glycoconj. J. 13, 187-194 (1996)
7. Kyogashima, M., Sakai, T., Onaya, J., Hara, A.: Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system. Glycoconj. J. 18, 245-251 (2001)
8. Kyogashima, M., Onaya, J., Hara, A., Taketomi, T.: Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model. Glycoconj. J. 15, 915-922 (1998)
9. Kyogashima, M., Onaya, J., Hara, A., Taketomi, T.: Contradictory functions of sulfatide in the blood coagulation system as coagulant and anticoagulant. Acta. Biochim. Pol. 45, 493-499 (1998)
10. Mitropoulos, K.A., Reeves, B.E., Miller, G.J.: The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins. Blood Coagul. Fibrinolysis. 4, 943-951 (1993)
11. Ida, M., Satoh, A., Matsumoto, I., Kojima-Aikawa, K.: Human annexin V binds to sulfatide: contribution to regulation of blood coagulation. J. Biochem. (Tokyo) 135, 583-588 (2004)
12. Devaiah, A.K., Raife, T.J., Barton, J.A., Olson, J.D.: Inhibition of human platelet function by sulfatides. Blood Coagul. Fibrinolysis 11, 543-550 (2000)
13. Merten, M., Thiagarajan, P.: Role for sulfatides in platelet aggregation. Circulation 104, 2955-2960 (2001)
14. Borthakur, G., Cruz, MA., Dong, JF., McIntire, L., Li, F., Lopez, J.A., Thiagarajan, P.: Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood. J. Thromb. Haemost. 1, 1288-1295 (2003)
15. Merten, M., Beythien, C., Gutensohn, K., Kuhnl, P., Meinertz, T., Thiagarajan, P.: Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation. Arterioscler. Thromb. Vasc. Biol. 25, 258-263 (2005)
16. Shimazawa, M., Kondo, K., Hara, H., Nakashima, M., Umemura, K.: Sulfatides, L- and P-selectin ligands, exacerbate the intimal hyperplasia occurring after endothelial injury. Eur. J. Pharmacol. 520, 118-126 (2005)
17. Kyogashima, M.: The role of sulfatide in thrombogenesis and haemostasis. Arch. Biochem. Biophys. 426, 157-162 (2004)
18. Li, G., Hu, R., Kamijo, Y., Nakajima, T., Aoyama, T., Inoue, T., Node, K. Kannagi, R., Kyogashima, M., Hara, A.: Establishment of a quantitative, qualitative and high throughput analysis of sulfatides from small amounts of sera by MALDI-TOF MS. Anal. Biochem. 362, 1-7 (2007)
19. Attman, P.O., Samuelsson, O., Alaupovic, P.: Lipoprotein metabolism in renal failure. Am. J. Kidney Dis. 21, 573-592 (1993)
20. Aoyama, T., Peters, J.M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., Gonzalez, F.J.: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 273, 5678-5684 (1998)
21. Kasiske, B.L.: Hyperlipidemia in patients with chronic renal disease. Am. J. Kidney Dis. 32, 142-156 (1998)
22. Levey, A., Beto, J.A., Coronado, B.E., Eknoyan, G., Foley, R.N., Kasiske, B.L., Klag, M.J., Mailloux, L.U., Manske, C.L., Meyer, K.B., Parfrey, P.S., Pfeffer, M.A., Wenger, N.K., Wilson, P.W., Wright, J.T. Jr.,: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am. J. Kidney Dis. 32, 853-906 (1998)
23. Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., Coresh, J., Culleton, B., Hamm, L.L., McCullough, P.A., Kasiske, B.L., Kelepouris, E., Klag, M.J., Parfrey, P., Raij, M.L., D.J., Spinosa, Wilson, P.W.: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 108, 2154-2169 (2003)
24. Roberts, M.A., Hare, D.L., Ratnaike, S., Ierino, F.L.: Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease. Am. J. Kidney Dis. 48, 341-360 (2006)
25. Sugiyama, E. Hara, A., Uemura, A.: A quantitative analysis of serum sulfatides by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction. Anal. Biochem. 274, 90-97 (1999)
26. Hara, A., Radin, N.S.: Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 90, 420-426 (1978)
27. Roberts, D.D., Williams, S.B., Gralnick, H.R., Ginsburg V.: von Willebrand factor binds specifically to sulfated glycolipids. J. Biol. Chem. 261, 3306-3309 (1986)
28. Kyogashima, M., Tamiya-Koizumi, K., Ehara, T., Li, G., Hu, R., Hara, A., Aoyama, T., Kannagi, R.: Rapid demonstration of diversity of sulfatide molecular species from biological materials by MALDI-TOF MS. Glycobiology. 16, 719-728 (2006)